GENEVA, July 9 -- SHANGHAI QILU PHARMACEUTICAL RESEARCH AND DEVELOPMENT CENTRE LTD. filed a patent application (CN2025/145426) for “BINDING MOLECULE FOR CD70 AND USE THEREOF”. With publication no. WO/2026/145227, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....